The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IL-1 receptor antagonist for prevention of severe immune effector cell-associated neurotoxicity syndrome.
 
Caspian Oliai
Research Funding - Amgen; Arog; Jazz Pharmaceuticals; Novartis; Orca Bio; Pfizer
 
Anna Crosetti
No Relationships to Disclose
 
Sven De Vos
Consulting or Advisory Role - Bayer; Verastem
Research Funding - Acerta Pharma; Allogene Therapeutics; Celgene; Epizyme; Incyte; Kite, a Gilead Company; Pharmacyclics/Janssen; Portola Pharmaceuticals; VelosBio
 
Herbert Eradat
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; BeiGene; Roche
Research Funding - Arquer Diagnostics; Juno Therapeutics; Kite/Gilead; Merck; Roche
 
Monica Diane Mead
Research Funding - Acerta Pharma; Curis; Daiichi Sankyo; Verastem
 
Sarah Marie Larson
Consulting or Advisory Role - Bristol Meyers Sqibb
Speakers' Bureau - Takeda
Research Funding - Abbvie; BiolineRx; Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Steven Tsai
No Relationships to Disclose
 
Annabel Liu
No Relationships to Disclose
 
Gina Khachatrian
No Relationships to Disclose
 
Christopher Hannigan
No Relationships to Disclose
 
Reiko E. Yamada
No Relationships to Disclose
 
Neiki Rokni
No Relationships to Disclose
 
John Timmerman
Honoraria - Kite/Gilead
Consulting or Advisory Role - Celgene; Genmab; Kite/Gilead; Seagen
Research Funding - Bristol-Myers Squibb; ImmunGene; Kite, a Gilead company; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb